pharmaceuticals-and-healthcare

United States Whole Exome Sequencing Market Report 2016


Published On : Oct 2016

Category : Biotechnology

No. of Pages : 118 pages

  • $3400
  • $6800

Please click below to avail discount on this report

Notes:
Sales, means the sales volume of Whole Exome Sequencing
Revenue, means the sales value of Whole Exome Sequencing

This report studies sales (consumption) of Whole Exome Sequencing in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Illumina, Inc. (U.S.)
Life Technologies (acquired by Thermo Fisher Scientific, Inc.) (U.S.)
Roche NimbleGen, Inc. (U.S.)
Agilent Technologies (U.S.)
BGI (Beijing Genomics Institute, China)
Eurofins Genomics, Inc. (Germany)
Sengenics (U.S.)
GENEWIZ, Inc. (U.S.)
Knome, Inc. (U.S.)
Macrogen, Inc. (South Korea)
Ambry Genetics (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Sequencing by Synthesis
Ion Semiconductor Sequencing
Others
Split by applications, this report focuses on sales, market share and growth rate of Whole Exome Sequencing in each application, can be divided into
Diagnostics
Cancer
Monogenic Disorders
Diabetes
Others
Drug Discovery and Development
Personalized Medicine
Agriculture and Animal Research
Others

A massive portion of the overall impetus that players and markets associated with biotechnology are receiving, comes from the rapidly increasing government support. Developed economies are especially ahead of the game in terms of research and development, as well as the incorporation of ready products into the commercial markets. However, it should be noted that the average time to market for a standard biotechnology product is exceedingly higher than conventional medical products. Despite this, players are becoming ever ready to tackle the more promising fields in biotechnology, namely stem cell technology, nanotechnology, and genetic cloning. This field is poised to be an inseparable part of the healthcare industry, and is in need of heavy efforts on the research and development side.

The United states whole exome sequencing market report 2016 is a very different market loaded with exceptional competitors and very specific customer and end user appeals. The improvement of innovations is additionally in high demand, with the developed economies demonstrating a more prominent consideration in the advancement of cutting edge advances than the developing economies. The report considers every such element while surveying the upcoming expected openings for players in the market over the coming years. It therefore converts the data presented into a matter of point of view, and offers the most ideal one for the market as far as getting favored by the key drivers and patterns influencing the market is concerned, while evading the hindrances that could prevent the advance of the players. The establishment for this investigation is made by getting the readers of this report familiar with the basic syntax of the market as it is important to completely comprehend its progression that the said entities are expected to promote themselves on.

The regional examination of the United states whole exome sequencing market report 2016 can be depicted as a widely inclusive survey of the key locations, from the points of view of these locations as specified through their existing player base and the general end user reports for them. This is a doubly useful approach in market examination for the regional companies, as it helps them see precisely what their field of operation needs, as far as their end users are concerned. Moreover, investors will be able to figure out which organization they can pay special attention to when attempting to extend their investments profiles. Additionally, the level of detail with which every segment and region is depicted can build this report up to be a convenient guide for them with regards to enhancing their place in a particular region or country, or with regards to entering new market fruitfully over the coming years.

The competitive analysis presented in the report on the United states whole exome sequencing market report 2016 can be an imperative device in the overall arsenal that a market player possesses. A careful learning and understanding of the competitive profiles and the contentions between players is a crucial bit of data needed by all market players, and it is the thing that this report gives to every client. The level of customization for every player takes into consideration an extraordinary standpoint for them, taking into account significantly more noteworthy data.

Table of Contents

United States Whole Exome Sequencing Market Report 2016
1 Whole Exome Sequencing Overview
1.1 Product Overview and Scope of Whole Exome Sequencing
1.2 Classification of Whole Exome Sequencing
1.2.1 Sequencing by Synthesis
1.2.2 Ion Semiconductor Sequencing
1.2.3 Others
1.3 Application of Whole Exome Sequencing
1.3.1 Diagnostics
1.3.2 Cancer
1.3.3 Monogenic Disorders
1.3.4 Diabetes
1.3.5 Others
1.3.6 Drug Discovery and Development
1.3.7 Personalized Medicine
1.3.8 Agriculture and Animal Research
1.3.9 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Whole Exome Sequencing (2011-2021)
1.4.1 United States Whole Exome Sequencing Sales and Growth Rate (2011-2021)
1.4.2 United States Whole Exome Sequencing Revenue and Growth Rate (2011-2021)

2 United States Whole Exome Sequencing Competition by Manufacturers
2.1 United States Whole Exome Sequencing Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Whole Exome Sequencing Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Whole Exome Sequencing Average Price by Manufactures (2015 and 2016)
2.4 Whole Exome Sequencing Market Competitive Situation and Trends
2.4.1 Whole Exome Sequencing Market Concentration Rate
2.4.2 Whole Exome Sequencing Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Whole Exome Sequencing Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Whole Exome Sequencing Sales and Market Share by Type (2011-2016)
3.2 United States Whole Exome Sequencing Revenue and Market Share by Type (2011-2016)
3.3 United States Whole Exome Sequencing Price by Type (2011-2016)
3.4 United States Whole Exome Sequencing Sales Growth Rate by Type (2011-2016)

4 United States Whole Exome Sequencing Sales (Volume) by Application (2011-2016)
4.1 United States Whole Exome Sequencing Sales and Market Share by Application (2011-2016)
4.2 United States Whole Exome Sequencing Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Whole Exome Sequencing Manufacturers Profiles/Analysis
5.1 Illumina, Inc. (U.S.)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Whole Exome Sequencing Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Illumina, Inc. (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Life Technologies (acquired by Thermo Fisher Scientific, Inc.) (U.S.)
5.2.2 Whole Exome Sequencing Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Life Technologies (acquired by Thermo Fisher Scientific, Inc.) (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Roche NimbleGen, Inc. (U.S.)
5.3.2 Whole Exome Sequencing Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Roche NimbleGen, Inc. (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Agilent Technologies (U.S.)
5.4.2 Whole Exome Sequencing Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Agilent Technologies (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 BGI (Beijing Genomics Institute, China)
5.5.2 Whole Exome Sequencing Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 BGI (Beijing Genomics Institute, China) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Eurofins Genomics, Inc. (Germany)
5.6.2 Whole Exome Sequencing Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Eurofins Genomics, Inc. (Germany) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Sengenics (U.S.)
5.7.2 Whole Exome Sequencing Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Sengenics (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 GENEWIZ, Inc. (U.S.)
5.8.2 Whole Exome Sequencing Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 GENEWIZ, Inc. (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Knome, Inc. (U.S.)
5.9.2 Whole Exome Sequencing Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Knome, Inc. (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Macrogen, Inc. (South Korea)
5.10.2 Whole Exome Sequencing Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Macrogen, Inc. (South Korea) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Ambry Genetics (U.S.)

6 Whole Exome Sequencing Manufacturing Cost Analysis
6.1 Whole Exome Sequencing Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Whole Exome Sequencing

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Whole Exome Sequencing Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Whole Exome Sequencing Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Whole Exome Sequencing Market Forecast (2016-2021)
10.1 United States Whole Exome Sequencing Sales, Revenue Forecast (2016-2021)
10.2 United States Whole Exome Sequencing Sales Forecast by Type (2016-2021)
10.3 United States Whole Exome Sequencing Sales Forecast by Application (2016-2021)
10.4 Whole Exome Sequencing Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List of Tables and Figures

Figure Picture of Whole Exome Sequencing
Table Classification of Whole Exome Sequencing
Figure United States Sales Market Share of Whole Exome Sequencing by Type in 2015
Figure Sequencing by Synthesis Picture
Figure Ion Semiconductor Sequencing Picture
Figure Others Picture
Table Application of Whole Exome Sequencing
Figure United States Sales Market Share of Whole Exome Sequencing by Application in 2015
Figure Diagnostics Examples
Figure Cancer Examples
Figure Monogenic Disorders Examples
Figure Diabetes Examples
Figure Others Examples
Figure Drug Discovery and Development Examples
Figure Personalized Medicine Examples
Figure Agriculture and Animal Research Examples
Figure Others Examples
Figure United States Whole Exome Sequencing Sales and Growth Rate (2011-2021)
Figure United States Whole Exome Sequencing Revenue and Growth Rate (2011-2021)
Table United States Whole Exome Sequencing Sales of Key Manufacturers (2015 and 2016)
Table United States Whole Exome Sequencing Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Whole Exome Sequencing Sales Share by Manufacturers
Figure 2016 Whole Exome Sequencing Sales Share by Manufacturers
Table United States Whole Exome Sequencing Revenue by Manufacturers (2015 and 2016)
Table United States Whole Exome Sequencing Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Whole Exome Sequencing Revenue Share by Manufacturers
Table 2016 United States Whole Exome Sequencing Revenue Share by Manufacturers
Table United States Market Whole Exome Sequencing Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Whole Exome Sequencing Average Price of Key Manufacturers in 2015
Figure Whole Exome Sequencing Market Share of Top 3 Manufacturers
Figure Whole Exome Sequencing Market Share of Top 5 Manufacturers
Table United States Whole Exome Sequencing Sales by Type (2011-2016)
Table United States Whole Exome Sequencing Sales Share by Type (2011-2016)
Figure United States Whole Exome Sequencing Sales Market Share by Type in 2015
Table United States Whole Exome Sequencing Revenue and Market Share by Type (2011-2016)
Table United States Whole Exome Sequencing Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Whole Exome Sequencing by Type (2011-2016)
Table United States Whole Exome Sequencing Price by Type (2011-2016)
Figure United States Whole Exome Sequencing Sales Growth Rate by Type (2011-2016)
Table United States Whole Exome Sequencing Sales by Application (2011-2016)
Table United States Whole Exome Sequencing Sales Market Share by Application (2011-2016)
Figure United States Whole Exome Sequencing Sales Market Share by Application in 2015
Table United States Whole Exome Sequencing Sales Growth Rate by Application (2011-2016)
Figure United States Whole Exome Sequencing Sales Growth Rate by Application (2011-2016)
Table Illumina, Inc. (U.S.) Basic Information List
Table Illumina, Inc. (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Illumina, Inc. (U.S.) Whole Exome Sequencing Sales Market Share (2011-2016)
Table Life Technologies (acquired by Thermo Fisher Scientific, Inc.) (U.S.) Basic Information List
Table Life Technologies (acquired by Thermo Fisher Scientific, Inc.) (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Life Technologies (acquired by Thermo Fisher Scientific, Inc.) (U.S.) Whole Exome Sequencing Sales Market Share (2011-2016)
Table Roche NimbleGen, Inc. (U.S.) Basic Information List
Table Roche NimbleGen, Inc. (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche NimbleGen, Inc. (U.S.) Whole Exome Sequencing Sales Market Share (2011-2016)
Table Agilent Technologies (U.S.) Basic Information List
Table Agilent Technologies (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies (U.S.) Whole Exome Sequencing Sales Market Share (2011-2016)
Table BGI (Beijing Genomics Institute, China) Basic Information List
Table BGI (Beijing Genomics Institute, China) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
Table BGI (Beijing Genomics Institute, China) Whole Exome Sequencing Sales Market Share (2011-2016)
Table Eurofins Genomics, Inc. (Germany) Basic Information List
Table Eurofins Genomics, Inc. (Germany) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eurofins Genomics, Inc. (Germany) Whole Exome Sequencing Sales Market Share (2011-2016)
Table Sengenics (U.S.) Basic Information List
Table Sengenics (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sengenics (U.S.) Whole Exome Sequencing Sales Market Share (2011-2016)
Table GENEWIZ, Inc. (U.S.) Basic Information List
Table GENEWIZ, Inc. (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
Table GENEWIZ, Inc. (U.S.) Whole Exome Sequencing Sales Market Share (2011-2016)
Table Knome, Inc. (U.S.) Basic Information List
Table Knome, Inc. (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Knome, Inc. (U.S.) Whole Exome Sequencing Sales Market Share (2011-2016)
Table Macrogen, Inc. (South Korea) Basic Information List
Table Macrogen, Inc. (South Korea) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Macrogen, Inc. (South Korea) Whole Exome Sequencing Sales Market Share (2011-2016)
Table Ambry Genetics (U.S.) Basic Information List
Table Ambry Genetics (U.S.) Whole Exome Sequencing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ambry Genetics (U.S.) Whole Exome Sequencing Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Whole Exome Sequencing
Figure Manufacturing Process Analysis of Whole Exome Sequencing
Figure Whole Exome Sequencing Industrial Chain Analysis
Table Raw Materials Sources of Whole Exome Sequencing Major Manufacturers in 2015
Table Major Buyers of Whole Exome Sequencing
Table Distributors/Traders List
Figure United States Whole Exome Sequencing Production and Growth Rate Forecast (2016-2021)
Figure United States Whole Exome Sequencing Revenue and Growth Rate Forecast (2016-2021)
Table United States Whole Exome Sequencing Production Forecast by Type (2016-2021)
Table United States Whole Exome Sequencing Consumption Forecast by Application (2016-2021)

Request a Sample Copy

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top